Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary Shares
Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020     53,045,510          
Beginning balance at Dec. 31, 2020 $ 291,422   $ 53,046 $ 0 $ 289,344 $ (3,174) $ (47,794)  
Beginning balance (in shares) at Dec. 31, 2020       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shareholders’ capital distributions (60,000)       (60,000)      
Share-based compensation 156       156      
Net income (loss) 20,629           20,629  
Other comprehensive income (loss) 236         236    
Ending balance (in shares) at Nov. 08, 2021     53,045,510          
Ending balance at Nov. 08, 2021 $ 252,443   $ 53,046 $ 0 229,500 (2,938) (27,165)  
Ending balance (in shares) at Nov. 08, 2021       0        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]              
Beginning balance (in shares) at Dec. 31, 2020     53,045,510          
Beginning balance at Dec. 31, 2020 $ 291,422   $ 53,046 $ 0 289,344 (3,174) (47,794)  
Beginning balance (in shares) at Dec. 31, 2020       0        
Ending balance (in shares) at Dec. 31, 2021     157,237,435          
Ending balance at Dec. 31, 2021 1,081,618 $ (1,545) $ 157,237 $ 0 1,670,033 (7,135) (738,517) $ (1,545)
Ending balance (in shares) at Dec. 31, 2021       0        
Beginning balance (in shares) at Nov. 08, 2021     53,045,510          
Beginning balance at Nov. 08, 2021 252,443   $ 53,046 $ 0 229,500 (2,938) (27,165)  
Beginning balance (in shares) at Nov. 08, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (682,149)              
Ending balance (in shares) at Dec. 31, 2021     157,237,435          
Ending balance at Dec. 31, 2021 1,081,618 (1,545) $ 157,237 $ 0 1,670,033 (7,135) (738,517) (1,545)
Ending balance (in shares) at Dec. 31, 2021       0        
Beginning balance (in shares) at Nov. 09, 2021     156,937,410          
Beginning balance at Nov. 09, 2021 1,476,881   $ 156,937 $ 0 1,376,312 0 (56,368)  
Beginning balance (in shares) at Nov. 09, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of ordinary shares issued to Director Subscribers (in shares)     200,000          
Sale of ordinary shares issued to Director Subscribers 2,000   $ 200   1,800      
Share-based compensation 290,846       290,846      
Ordinary shares issued related to share-based compensation (in shares)     100,000          
Ordinary shares issued related to share-based compensation 1,175   $ 100   1,075      
Warrants exercised (in shares)     25          
Net income (loss) (682,149)           (682,149)  
Other comprehensive income (loss) (7,135)         (7,135)    
Ending balance (in shares) at Dec. 31, 2021     157,237,435          
Ending balance at Dec. 31, 2021 1,081,618 $ (1,545) $ 157,237 $ 0 1,670,033 (7,135) (738,517) $ (1,545)
Ending balance (in shares) at Dec. 31, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 14,649       14,649      
Ordinary shares issued related to share-based compensation (in shares)     5,952,992          
Ordinary shares issued related to share-based compensation 0   $ 5,954   (5,954)      
Liability portion of founders advisory fees - related party reclassified to additional paid in capital 19,568       19,568      
Warrants exercised (in shares)     44,115          
Warrants exercised $ 529   $ 44   485      
Ordinary shares repurchased (in shares) 6,436,736     6,436,736        
Ordinary shares repurchased $ (49,341)     $ (49,341)        
Net income (loss) 91,758           91,758  
Other comprehensive income (loss) $ (18,336)         (18,336)    
Ending balance (in shares) at Dec. 31, 2022 163,234,542   163,234,542          
Ending balance at Dec. 31, 2022 $ 1,138,900   $ 163,235 $ (49,341) 1,698,781 (25,471) (648,304)  
Ending balance (in shares) at Dec. 31, 2022 6,436,736     6,436,736        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation $ 1,596       1,596      
Ordinary shares issued related to share-based compensation (in shares)     1,831,653          
Ordinary shares issued related to share-based compensation 0   $ 1,832   (1,832)      
Liability portion of founders advisory fees - related party reclassified to additional paid in capital $ 2,618       2,618      
Ordinary shares repurchased (in shares) 12,178,454     12,178,454        
Ordinary shares repurchased $ (64,066)     $ (64,066)        
Net income (loss) 67,486           67,486  
Other comprehensive income (loss) $ 5,761         5,761    
Ending balance (in shares) at Dec. 31, 2023 165,066,195   165,066,195          
Ending balance at Dec. 31, 2023 $ 1,152,295   $ 165,067 $ (113,407) $ 1,701,163 $ (19,710) $ (580,818)  
Ending balance (in shares) at Dec. 31, 2023 18,615,190     18,615,190